black box warning semaglutide Popular weight-loss drugs shouldn't carry suicide warnings, FDA says What are the black box

A 2025 review by Jozwiak and colleagues surveys the peptides multifunctionality and possible medical applications (PMC11859134), and is a useful map of what has and has not been established

Sources Hamed, K., Alosaimi, M

Retatrutide has attracted interest because of its activity across GLP-1, GIP and glucagon receptor pathways

Reaction mechanisms of allicin and allyl-mixed disulfides with proteins and small thiol molecules

1 H NMR (500 MHz, CD 3 CN) 7.38 (bs, 1H), 7.347.27 (m, 2H), 7.036.96 (m, 2H), 4.88 (s, 1H), 4.79 (s, 1H), 4.77 (d, J = 2.4 Hz, 3H), 4.41 (d, J = 6.2 Hz, 2H), 2.86 (t, J = 2.4 Hz, 1H) ppm

For a market still arguing about where compounded semaglutide ends and counterfeit research peptide begins, that matters